Try our Advanced Search for more refined results
MOMENTA PHARMACEUTICALS, INC. v. MYLAN PHARMACEUTICALS, INC. et al
Case Number:
2:22-cv-00750
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
September 21, 2022
Viatris Suppliers Want Out Of J&J Unit's MS Drug IP Suit
Three drug manufacturers for Viatris have urged a Pennsylvania federal judge to cut them loose from a patent suit lodged by a Johnson & Johnson branch over a generic multiple sclerosis treatment, arguing that the court lacks jurisdiction and the overseas suppliers can't be held liable for the allegedly infringing products.
-
May 24, 2022
Mylan Hit With Infringement Suit Over MS Generic Drug
Mylan has been using Momenta's patented manufacturing methods to make a generic version of a multiple sclerosis treatment, the Johnson & Johnson unit alleged in a new infringement lawsuit in Pennsylvania federal court.